Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: GCP investigator obligations

Investigator Responsibilities in Clinical Trials: GCP Compliance and Best Practices

Posted on May 14, 2025 digi By digi

Investigator Responsibilities in Clinical Trials: GCP Compliance and Best Practices Mastering Investigator Responsibilities for Ethical and Compliant Clinical Trials Investigators are central figures in clinical research, entrusted with protecting participant rights, ensuring protocol adherence, and maintaining data integrity. Their leadership and commitment to Good Clinical Practice (GCP) are vital to the ethical, scientific, and regulatory…

Read More “Investigator Responsibilities in Clinical Trials: GCP Compliance and Best Practices” »

Good Clinical Practice (GCP) and Compliance, Investigator Responsibilities

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Post-Hoc Analyses and Subgroup Evaluation in Phase 3 Clinical Trials: Purpose, Pitfalls, and Strategic Applications
  • Use of Phase 1 Data in NDA/BLA Submissions: What Regulators Look For
  • Go/No-Go Decision Criteria for Advancing to Phase 3
  • Multinational Post-Marketing Surveillance Programs in Phase 4 Clinical Trials
  • Real-World Data Integration into Phase 3 Trials: Methods, Benefits, and Regulatory Considerations

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme